LCM
VYGR icon

Landscape Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Landscape Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,306
Closed -$96K – 1096
2022
Q2 		$96K Buy
+16,306
New +$110K 0.01% 907
2018
Q3 		– Sell
-10,504
Closed -$205K – 803
2018
Q2 		$205K Buy
+10,504
New +$208K 0.02% 465

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Landscape Capital Management's VYGR Position: Q3 2022 in Review

Landscape Capital Management sold out of Voyager Therapeutics (VYGR) in Q3 2022, closing a stake of 16,306 shares — an estimated $96K sold.

Landscape Capital Management first reported a position in VYGR in Q2 2018 and held it in 2 quarters. The position peaked at $205K in Q2 2018. 69 funds tracked by Wall St. Rank hold VYGR as of Q3 2022.

  • Landscape Capital Management reported no remaining Voyager Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Landscape Capital Management sold 16,306 Voyager Therapeutics shares in Q3 2022, an estimated $96K.
  • Landscape Capital Management first reported a position in Voyager Therapeutics in Q2 2018 and held it in 2 quarters.
  • Landscape Capital Management's Voyager Therapeutics position peaked at $205K in Q2 2018.
  • 69 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2022.

Based on Landscape Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.